Anika Therapeutics (ANIK) Total Debt Growth (1y) (2011 - 2022)
Anika Therapeutics (ANIK) Total Debt Growth (1y) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 41.53% |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -74.42% |
| Mar 31, 2022 | -82.68% |
| Dec 31, 2021 | -67.04% |
| Sep 30, 2021 | -82.80% |
| Jun 30, 2021 | -66.26% |
| Sep 30, 2013 | -13.79% |
| Jun 30, 2013 | -13.33% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | -12.50% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 0.00% |
| Dec 31, 2011 | 0.00% |